Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XKR5 | CTRPv2 | pan-cancer | AAC | 0.5 | 0.0005 |
mRNA | INTS6L | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0005 |
mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.0005 |
mRNA | MC2R | CTRPv2 | pan-cancer | AAC | -0.36 | 0.0005 |
mRNA | VRK1 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0006 |
mRNA | TENM1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0006 |
mRNA | NKX2-2 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0006 |
mRNA | ZIC2 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0006 |
mRNA | GABRA3 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0006 |
mRNA | RPL22 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.0006 |